Latest filing published 22 Nov 2024 for Caribou Biosciences, Inc..
Filing timeline
BuySaleInsider track record
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Ryan Fischesser: trading record in brief
This profile gathers the share dealings of Ryan Fischesser in Caribou Biosciences, Inc., where the filings describe the role as senior executive. We count 13 filings; the first trade dates from 11 October 2021 and the latest from 20 November 2024.
Market trades split into 4 purchases (€33k) and 1 sale (€110k). The net balance comes to €77k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 6 option exercises.
Half of the purchases are above €3,391 and half below. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 22 November 2024, reports a share grant in Caribou Biosciences, Inc. The latest purchase dates back some time: it was published 1,761 days ago, on 12 January 2022. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ryan Fischesser
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares0Common StockSEC:0001871155-24-000005:0
- 10,000 shares@ US$10.795883.4% of flowCommon StockSEC:0001619856-22-000003:0
- 4,848 shares0Common StockSEC:0001209191-22-047368:0
- 1,136 shares@ US$2.692.3% of flowCommon StockSEC:0001209191-22-027696:0
- 1,136 shares@ US$2.692.2% of flowCommon StockSEC:0001209191-22-019808:0
- 569 shares@ US$2.691.1% of flowCommon StockSEC:0001209191-22-003062:0Canonical exit: 11 Apr 2022 (T+90)
- 1,136 shares@ US$2.692.2% of flowCommon StockSEC:0001209191-21-070797:0Canonical exit: 20 Mar 2022 (T+90)
- 1,746 shares@ US$2.693.3% of flowCommon StockSEC:0001209191-21-060289:0Canonical exit: 9 Jan 2022 (T+90)
8 of 8 declarations